Market Pulse
Daily · Oct 7, 2026 · data.go.kr + ECOS
KOSPI
6,803.90
-137.49 (-1.98%)
KOSDAQ
898.43
-21.49 (-2.34%)
KOSPI 200
1,073.63
-22.20 (-2.03%)
USD/KRW
1,340.40
068270KOSPI·May 27, 2026
Initiating Coverage: Time to Lead amid Drug Patent Expiry Cycle
KB Securities published a company analysis report on Celltrion, Inc. (068270) titled "Initiating Coverage: Time to Lead amid Drug Patent Expiry Cycle".
Summary
Covers Celltrion, Inc. (068270).
Covered stock
More on 068270
Top-tier performance, yet still undervalued vs. peersMirae Asset Securities · Jul 29, 2026Consensus miss unlikely to be repeated this yearMirae Asset Securities · Jan 06, 2026Cost ratio continues to improveMirae Asset Securities · Nov 05, 2025Earnings miss on lower Remsima IV sales and higher CMO shareMirae Asset Securities · May 13, 2025